Background and objective: CBD stones require intervention from two separate specialties: gastroenterologist and surgical team. Preferred methods for treatment are pre- or postoperative ERCP with endoscopic biliary sphincterotomy (EST), laparoscopic or open surgical bile duct clearance. It is unlikely that one option will be universally acceptable for all clinical circumstances in all centres. Disease status, patient demographics, availability of endoscopic, radiological and surgical expertise, and healthcare economics are the variables that will have signicant inuence on practice. Purpose of this study was to assess prevalence of CBD stones with their clinical prole and to evaluate management protocol and its complications. 50 patients aged >18 years having Radiologically diagnosed CBD Methods: stones are included in our study. According to study selection criteria, patient information sheet, blood tests, imaging studies, postop factors and an informed consent taken in their own language, Patients underwent one of procedures such as ERCP followed by Laparoscopic cholecystectomy or Laparoscopic CBD exploration with Laparoscopic cholecystectomy or Open exploration of CBD with Cholecystectomy. A total of 50 patients Results: were taken for ERCP in our study. All patients who underwent ERCP with endoscopic sphincterotomy and stone removal used either a Dormia basket or a Fogarty balloon. The rate of success of endoscopic retrograde cholangiopancreatography in removing CBD Stones was 46 out of 50 cases (92 percent). To Conclusion: summarize, no denite algorithm can be applied for management of common bile duct stones because patients' age, underlying general condition, and facilities for endoscopic, laparoscopic management are the only standardizable factors. The management differs from institution to institution, so the management of CBD stones must be tailored to the institution's resources.